- Home
- ELVN vs PGY Comparison
ELVN vs PGY Comparison
Compare ELVN & PGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELVN
- PGY
- Stock Information
- Founded
- ELVN 2016
- PGY 2016
- Country
- ELVN United States
- PGY United States
- Employees
- ELVN N/A
- PGY N/A
- Industry
- ELVN Biotechnology: Pharmaceutical Preparations
- PGY Finance: Consumer Services
- Sector
- ELVN Health Care
- PGY Finance
- Exchange
- ELVN Nasdaq
- PGY Nasdaq
- Market Cap
- ELVN 927.8M
- PGY 863.7M
- IPO Year
- ELVN 2020
- PGY N/A
- Fundamental
- Price
- ELVN $18.42
- PGY $14.58
- Analyst Decision
- ELVN Strong Buy
- PGY Strong Buy
- Analyst Count
- ELVN 4
- PGY 9
- Target Price
- ELVN $39.25
- PGY $21.61
- AVG Volume (30 Days)
- ELVN 260.6K
- PGY 1.9M
- Earning Date
- ELVN 05-13-2025
- PGY 05-07-2025
- Dividend Yield
- ELVN N/A
- PGY N/A
- EPS Growth
- ELVN N/A
- PGY N/A
- EPS
- ELVN N/A
- PGY N/A
- Revenue
- ELVN N/A
- PGY $1,076,961,000.00
- Revenue This Year
- ELVN N/A
- PGY $16.93
- Revenue Next Year
- ELVN N/A
- PGY $13.84
- P/E Ratio
- ELVN N/A
- PGY N/A
- Revenue Growth
- ELVN N/A
- PGY 23.69
- 52 Week Low
- ELVN $13.30
- PGY $8.20
- 52 Week High
- ELVN $30.03
- PGY $19.20
- Technical
- Relative Strength Index (RSI)
- ELVN 47.86
- PGY 71.79
- Support Level
- ELVN $17.76
- PGY $10.68
- Resistance Level
- ELVN $20.79
- PGY $12.05
- Average True Range (ATR)
- ELVN 1.37
- PGY 0.83
- MACD
- ELVN 0.12
- PGY 0.41
- Stochastic Oscillator
- ELVN 45.39
- PGY 99.27
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
About PGY Pagaya Technologies Ltd.
Pagaya Technologies Ltd is a financial technology company working to reshape the lending marketplace by using machine learning, data analytics, and sophisticated AI-driven credit and analysis technology. It was built to provide a comprehensive solution to enable the credit industry to deliver customers a positive experience while simultaneously enhancing the broader credit ecosystem. Its proprietary API seamlessly integrates into its next-gen infrastructure network of partners to deliver a premium customer user experience and greater access to credit. The company generates majority of its revenue from United States.